Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis

Acta Dermato-Venereologica

Volumn 89, Issue 4, 2009, Pages 432-433

  Baltà Cruz, Susana ^a   Alsina Gibert, Mercé ^a   Mozos Rocafort, Ana ^a   Cervera, Carlos ^a   Colomo Saperas, Lluís ^a   Del Río, Ana ^a   Estrach Panella, Teresa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B CHOLESTEROL SULFATE; INFLIXIMAB; MEGLUMINE ANTIMONATE; METHOTREXATE; METOTREXATO; PREDNISOLONE; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEISHMANIA; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69249114897     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0633     Document Type: Letter

References (12)

1. Strangfeld A, Listing J. Bacterial and opportunistic infections during anti-TNF therapy. Best Pract Res Clin Rheumatol 2006; 20: 1181-1195. (Pubitemid 44774817)
2. Aliaga L, Cobo F, Mediavilla JD, Bravo J, Osuna A, Amador JM, et al. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore) 2003; 82: 147-158. (Pubitemid 36578704)
3. Saha M, Shipley D, McBride S, Kennedy C, Vega-Lopez F. Atypical cutaneous leishmaniasis in two patients receiving low-dose methotrexate. Br J Dermatol 2006; 155: 830-833. (Pubitemid 44352568)
4. Gardner-Medwin JM, Powell RJ. One patient, two unusual conditions and three basic lessons. Ann Rheum Dis 1996; 55: 350-352.
5. Böer A, Blödorn-Schlicht N, Wiebels D, Steinkraus V, Falk TM. Unusual histopathological features of cutaneous leishmaniasis identified by polymerase chain reaction specific for Leishmania on paraffin-embedded skin biopsies. Br J Dermatol 2006; 155: 815-819. (Pubitemid 44352564)
6. Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardimon JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001, p. 267-268.
7. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 persons-years of observation. Arthritis Rheum 2007; 56: 1433-1439. (Pubitemid 46764070)
8. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151-3158.
9. Bassetti RM, Pizzorni C, Gradoni L, Del Bono V, Cutolo M, Viscoli C. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology 2006; 45: 1446-1448. (Pubitemid 44605486)
10. Bagalas V, Kioumis I, Argyropoulou P, Patakas D. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 2007; 26: 1344-1345. (Pubitemid 47034194)
11. Fabre S, Gibert C, Lechiche C, Dereure J, Jorgensen C, Sany J. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 2005; 3: 891-892. (Pubitemid 43040522)
12. Romani-Costa V, Sanchez C, Moya F, Estany C. Visceral leishmaniasis related to infliximab administration. Enferm Infecc Microbiol Clin 2004; 22: 310. (Pubitemid 38756638)